Homira Osman
Dr. Homira Osman is the vice-president of research, public policy, and programs at Muscular Dystrophy Canada. She has conducted extensive research on the high usage rates of immunoglobulin in Canada, identifying systemic factors that contribute to its overprescription. Her work aims to improve the understanding and regulation of immunoglobulin use, ensuring that patients receive appropriate treatment while managing the finite resources derived from human plasma.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 7.00 | 0.08% | +0% | 38,005,238 | 30,773 | $1,700,000 | 1,377$ |
| Totals | 1 | 38,005,238 | 30,773 | $1,700,000 | 1,377$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Dr. Homira Osman is the vice-president of research, public policy and programs at Muscular Dystrophy Canada and has conducted a study on immunoglobulin use.
7